Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Safety Technologies (MST) was a medical device company primarily known for developing innovative safety-engineered injection systems designed to prevent needle-stick injuries. The company's flagship product, the MST-100 safety needle, featured a proprietary mechanism that shielded the needle immediately after use, addressing a critical safety concern for healthcare workers. MST's technology was highly regarded for its ease of use and reliability in clinical settings. In 2002, the company was acquired by Becton Dickinson (BD), a global leader in medical technology, which integrated MST's safety features into its extensive portfolio of drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Safety Technologies.